Effects of the AT1 receptor blocker candesartan on myocardial ischemia/reperfusion in isolated rat hearts. 2014

C Murat Songur, and Merve Ozenen Songur, and Sinan Sabit Kocabeyoglu, and Bilgen Basgut
Department of Cardiovascular Surgery, Turkey Yuksek Ihtisas Hospital Ankara, Turkey.

BACKGROUND We sought to investigate the effects of the angiotension II receptor blocker candesartan on ischemia-reperfusion injury using a cardioplegia arrested isolated rat heart model. METHODS Ischemia-reperfusion injury was induced in isolated rat hearts with 40 minutes of global ischemia followed by a 30-minute reperfusion protocol. Throughout the experiment, constant pressure perfusion was achieved using a Langendorff apparatus. Cardioplegic solution alone, and in combination with candesartan, was administered before ischemia and 20 minutes after ischemia. Post-ischemic recovery of contractile function, left ventricular developed pressure, left ventricular end-diastolic pressure and contraction and relaxation rates were evaluated. RESULTS In the control group, left ventricular developed pressure, rate pressure product, contraction and relaxation rates and coronary flow significantly decreased but coronary resistance increased following reperfusion. With the administration of candesartan alone, parameters did not differ compared to controls. Contractile parameters improved in the group that received candesartan in combination with the cardioplegia compared to the group that received cardioplegia alone; however, the difference between these two groups was insignificant. CONCLUSIONS In this study, the addition of candesartan to a cardioplegic arrest protocol routinely performed during cardiac surgery did not provide a significant advantage in protection against ischemia-reperfusion injury compared with the administration of cardioplegic solution alone.

UI MeSH Term Description Entries
D008297 Male Males
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D001713 Biphenyl Compounds Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings. Compounds, Biphenyl
D013318 Stroke Volume The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume. Ventricular Ejection Fraction,Ventricular End-Diastolic Volume,Ventricular End-Systolic Volume,Ejection Fraction, Ventricular,Ejection Fractions, Ventricular,End-Diastolic Volume, Ventricular,End-Diastolic Volumes, Ventricular,End-Systolic Volume, Ventricular,End-Systolic Volumes, Ventricular,Fraction, Ventricular Ejection,Fractions, Ventricular Ejection,Stroke Volumes,Ventricular Ejection Fractions,Ventricular End Diastolic Volume,Ventricular End Systolic Volume,Ventricular End-Diastolic Volumes,Ventricular End-Systolic Volumes,Volume, Stroke,Volume, Ventricular End-Diastolic,Volume, Ventricular End-Systolic,Volumes, Stroke,Volumes, Ventricular End-Diastolic,Volumes, Ventricular End-Systolic
D013777 Tetrazoles
D015428 Myocardial Reperfusion Injury Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm. Reperfusion Injury, Myocardial,Injury, Myocardial Reperfusion,Myocardial Ischemic Reperfusion Injury,Injuries, Myocardial Reperfusion,Myocardial Reperfusion Injuries,Reperfusion Injuries, Myocardial
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

C Murat Songur, and Merve Ozenen Songur, and Sinan Sabit Kocabeyoglu, and Bilgen Basgut
January 1999, Journal of the American Society of Nephrology : JASN,
C Murat Songur, and Merve Ozenen Songur, and Sinan Sabit Kocabeyoglu, and Bilgen Basgut
September 1999, European journal of pharmacology,
C Murat Songur, and Merve Ozenen Songur, and Sinan Sabit Kocabeyoglu, and Bilgen Basgut
December 1996, Circulation,
C Murat Songur, and Merve Ozenen Songur, and Sinan Sabit Kocabeyoglu, and Bilgen Basgut
September 1998, Circulation research,
C Murat Songur, and Merve Ozenen Songur, and Sinan Sabit Kocabeyoglu, and Bilgen Basgut
September 2001, American journal of physiology. Heart and circulatory physiology,
C Murat Songur, and Merve Ozenen Songur, and Sinan Sabit Kocabeyoglu, and Bilgen Basgut
July 1993, Japanese heart journal,
C Murat Songur, and Merve Ozenen Songur, and Sinan Sabit Kocabeyoglu, and Bilgen Basgut
January 1998, Basic research in cardiology,
C Murat Songur, and Merve Ozenen Songur, and Sinan Sabit Kocabeyoglu, and Bilgen Basgut
July 2003, Clinical nephrology,
C Murat Songur, and Merve Ozenen Songur, and Sinan Sabit Kocabeyoglu, and Bilgen Basgut
January 1999, Journal of the American Society of Nephrology : JASN,
C Murat Songur, and Merve Ozenen Songur, and Sinan Sabit Kocabeyoglu, and Bilgen Basgut
July 1994, The Journal of thoracic and cardiovascular surgery,
Copied contents to your clipboard!